High frequency of skewed X inactivation in young breast cancer patients

被引:67
作者
Kristiansen, M
Langerod, A
Knudsen, GP
Weber, BL
Borresen-Dale, AL
Orstavik, KH [1 ]
机构
[1] Univ Hosp, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway
[2] Univ Oslo, Inst Med Genet, Oslo 3, Norway
[3] Norwegian Radium Hosp, Inst Canc Res, Dept Genet, Oslo, Norway
[4] Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA
[5] Univ Oslo, Inst Lab Med, N-0316 Oslo, Norway
关键词
D O I
10.1136/jmg.39.1.30
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction: Patients with invasive ovarian cancer were recently shown to have a higher frequency of skewed X chromosome inactivation in peripheral blood cells compared to patients with borderline cancer and controls. In this study, we analysed the X inactivation pattern in peripheral blood from 216 breast cancer patients. Methods: X inactivation analysis was performed using Hpall predigestion of DNA followed by PCR of the highly polymorphic CAG repeat of the androgen receptor gene (AR), which amplifies the undigested inactive X chromosome only. The X inactivation pattern was classified as skewed when 90% or more of the cells preferentially used one X chromosome. Results: Young breast cancer patients (27-45 years) had a higher frequency of skewed X inactivation than young controls (13 and 1%, respectively) (p=0.009), whereas no difference was found for middle aged and older patients compared to controls of a similar age. Conclusions: A germline mutation in an X linked tumour suppressor gene may give a proliferative advantage to cells with this mutation on the active X chromosome, thus causing skewed X inactivation and an increased risk for developing cancer. Another possible explanation could be that females with a constitutionally skewed X inactivation pattern are more susceptible to develop breast cancer because of an X linked low penetrance susceptibility allele that is affected by the inactivation pattern.
引用
收藏
页码:30 / 33
页数:4
相关论文
共 20 条
[1]  
ALLEN RC, 1994, AM J HUM GENET, V54, P25
[2]  
ALLEN RC, 1992, AM J HUM GENET, V51, P1229
[3]  
Belmont JW, 1996, AM J HUM GENET, V58, P1101
[4]   Role of the androgen receptor in human breast cancer [J].
Birrell, SN ;
Hall, RE ;
Tilley, WD .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1998, 3 (01) :95-103
[5]   BRCA1 and BRCA2 and breast cancer incidence: A review [J].
Bishop, DT .
ANNALS OF ONCOLOGY, 1999, 10 :113-119
[6]   The causes and consequences of random and non-random X chromosome inactivation in humans [J].
Brown, CJ ;
Robinson, WP .
CLINICAL GENETICS, 2000, 58 (05) :353-363
[7]   Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer [J].
Buller, RE ;
Sood, AK ;
Lallas, T ;
Buekers, T ;
Skilling, JS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (04) :339-346
[8]  
Busque L, 1996, BLOOD, V88, P59
[9]   THE LENGTH AND LOCATION OF CAG TRINUCLEOTIDE REPEATS IN THE ANDROGEN RECEPTOR N-TERMINAL DOMAIN AFFECT TRANSACTIVATION FUNCTION [J].
CHAMBERLAIN, NL ;
DRIVER, ED ;
MIESFELD, RL .
NUCLEIC ACIDS RESEARCH, 1994, 22 (15) :3181-3186
[10]   X-linked genetic factors regulate hematopoietic stem-cell kinetics in females [J].
Christensen, K ;
Kristiansen, M ;
Hagen-Larsen, H ;
Skytthe, A ;
Bathum, L ;
Jeune, B ;
Andersen-Ranberg, K ;
Vaupel, JW ;
Orstavik, KH .
BLOOD, 2000, 95 (07) :2449-2451